Events
Optica Online Industry Meeting: Biosensing
26 September 2023 10:00 - 12:00
Eastern Time (US & Canada) (UTC - 04:00)Watch the Recording on YouTube
Scientists were able to identify and track the COVID-19 virus and develop vaccines and remedies with unprecedented speed, thanks to optics-based gene sequencing and biosensors that are now widely available and more affordable than even a decade ago. Biosensing is now applied in a wide array of applications, from glucose monitoring and pathogen detection, to cancer marking and food safety. This event will explore some opportunities in biosensing today that use optics and photonics.
Speakers
Anton Vasiliev
Ligentec, Project Manager
LIGENTEC is your manufacturing partner for Photonic Integrated Circuits (PIC). We provide next generation silicon photonics for customers in high-tech areas such as Communication, Quantum technologies, LiDAR and Sensing. Based on the ground-taking work of the laboratory of Professor Kippenberg at the Federal Institute of Technology in Lausanne (Switzerland), LIGENTEC commercialises the all-nitride-core technology, with which it enables the customers to develop their products in the industrial revolution 4.0.
Brian Maertz
CTO, Atomica
Atomica Corp. unleashes the power of Micro Electro-Mechanical Systems (MEMS) to help solve the great problems of our time. We partner with innovative companies to deliver breakthrough MEMS-based solutions in cloud computing, autonomous vehicles, cell therapy, molecular diagnostics, genomics, 5G, the Internet of Things (IoT), and more. “Our customers are on missions to cure disease and revolutionize sensing & communications.
Sebastian Huelck
Tec5 USA, CEO
tec5USA is an American technology company specializing in spectroscopic solutions. They design and manufacture high-performance spectrometers, sensors, and software for various industries, including pharmaceuticals, environmental monitoring, and research. Their products enable precise analysis of materials by measuring their spectral properties, facilitating advancements in science and industry.
Jeffrey Owen Katz
Sanguis Corporation, Co-Founder & Chief Science Officer
Sanguis Corporation is a NYS C-Corp, co-founded by Jeffrey Owen Katz, Ph.D., and Donna L. McCormick. It is dedicated to the development of innovative technology in the biomedical device and spectroscopy industries. Its mission is to provide advanced tools to help ensure the sustainability of the planet, as well as to improve the health and quality of life for all living beings.
